CareLit Fachartikel

Interest in integrative medicine among postmenopausal hormone receptor-positive breast cancer patients receiving letrozole treatment in the EvAluate-TM study

CC Hack, PA Fasching, T Fehm, J de Waal, M Rezai, B Baier, G Baake, HC Kolberg, M Guggenberger, M Warm, N Harbeck, R Wuerstlein, JU Deuker, P Dall, B Richter, G Wachsmann, C Brucker, JW Siebers, N Fersis, T Kuhn, C Wolf, HW Vollert, GP Breitbach, W Janni, R L… · Geburtshilfe und Frauenheilkunde · 2016 · Heft 10

Dokument
879247
CareLit-ID
Jahr
2016
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Geburtshilfe und Frauenheilkunde
Autor:innen
CC Hack, PA Fasching, T Fehm, J de Waal, M Rezai, B Baier, G Baake, HC Kolberg, M Guggenberger, M Warm, N Harbeck, R Wuerstlein, JU Deuker, P Dall, B Richter, G Wachsmann, C Brucker, JW Siebers, N Fersis, T Kuhn, C Wolf, HW Vollert, GP Breitbach, W Janni, R L…
Ausgabe
Heft 10 / 2016
Seiten
–
Erschienen: 2016-10-13 00:00:00
ISSN
0016-5751
DOI
10.1055/s-0036-1593261

Zusammenfassung

Background: Breast cancer patients make frequent use of complementary and alternative medicine (CAM), but few prospectively collected data are available specifically for postmenopausal breast cancer patients receiving adjuvant antihormonal therapy. The aim of the study was to identify the characteristics of patients who are interested in integrative medicine (IM). Methods: The EvAluate-TM study is a prospective noninterventional study, in which treatment with letrozole was evaluated in postmenopausal women with hormone receptor-positive primary breast cancer. 5,045 patients were enrolled at 339 certified breast…

Schlagworte

Geburtshilfe und Frauenheilkunde